"
Influence of hyperbaric oxygenation treatment (HBOT) on clinical outcomes (recurrent myocardial infarction and survival rate) during five-year monitoring period after acute myocardial infarction"
written by Eduard Dotsenko, Dmitry Salivonchyk, Osain Menizibeya Welcome, Konstantin Dotsenko, Sergei Salivonchyk, Valery Bobkov, Natalia Nikulina, Eugenia Semeniago, Svetlana Nerobeeva,
published by
Health,
Vol.6 No.1, 2014
has been cited by the following article(s):
|
[1]
|
Hyperbaric oxygen therapy post-primary PCI: Where is it going?
Cardiovascular Revascularization Medicine,
2021
DOI:10.1016/j.carrev.2021.03.017
|
|
|
|
|
[2]
|
Hyperbaric oxygen therapy following percutaneous coronary intervention for ST-segment elevation myocardial infarction
Cardiovascular Revascularization Medicine,
2020
DOI:10.1016/j.carrev.2020.04.031
|
|
|
|